Scientific publications

Treatment with tacrolimus in autoimmune diseases

Aug 1, 2004 | Magazine: Revista de Medicina de la Universidad de Navarra

Sádaba B, Azanza JR, García Quetglas E, Fernández V.


Tacrolimus is an immunosuppressive drug used most successfully as a primary drug to suppress the rejection of transplants. Tacrolimus may also be useful as a novel therapy for autoimmune disease. There are various reports in the bibliography about the use of tacrolimus in the treatment of some autoimmune diseases: inflammatory bowel disease, autoimmune hepatitis, cutaneous, neurologic, renal, endocrine or eye disease.

In this review of more than 130 papers, we discuss the rationale for the use of tacrolimus in autoimmune disease and report the clinical experience with the drug in the management of a variety of autoimmune diseases. But, although there are a lot questions that require future research (dose, duration of treatment, when to begin tacrolimus treatment, how to monitor it, etc.), there is also wide experience with tacrolimus in the treatment of this type of disease.

CITATION  Rev Med Univ Navarra. 2004 Jul-Sep;48(3):24-38